NCT05131061View on ClinicalTrials.gov

68Ga-Pentixafor PET/CT for the Subtyping Diagnosis of Primary Aldosteronism

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

November 11, 2021

Primary Completion Date

May 1, 2022

Study Completion Date

May 31, 2022

Conditions
Primary Aldosteronism
Interventions
DIAGNOSTIC_TEST

68Ga-Pentixafor PET/CT imaging

68Ga-Pentixafor PET/CT imaging

Trial Locations (1)

400016

The First Affilated Hospital of Chongqing Medical University, Chongqing

All Listed Sponsors
collaborator

The Affiliated Hospital Of Southwest Medical University

OTHER

lead

Qifu Li

OTHER

NCT05131061 - 68Ga-Pentixafor PET/CT for the Subtyping Diagnosis of Primary Aldosteronism | Biotech Hunter | Biotech Hunter